Mayo v. Prometheus

临床试验

计划入组 1,000 人 · 首次发布于 2018 年 11 月 28 日

Enrolling By Invitation

NCT05314426

Mayo Clinic Phage Program Biobank

计划入组 100 人 · 首次发布于 2022 年 4 月 6 日

Enrolling By Invitation

NCT07332598

Mayo Clinic Precure - Prospective Study

计划入组 100,000 人 · 首次发布于 2026 年 1 月 12 日

药物

查看全部 471 →

V-934/V-935

rHIgM12B7(Mayo Clinic)

Small Molecule

Approved

Phenoxymethylpenicillin(Pen VK)

生产企业：Eli lilly and co, Glaxosmithkline，另有 16 家

相关疾病：Actinomycosis, Animal bite，另有 16 项

C₁₆H₁₈N₂O₅S · Rx

机构

查看全部 54 →

PROMETHEUS LABORATORIES INC.

United States

Prometheus Biosciences, Inc.

United States

MAYO CLINIC

United States

资讯

查看全部 1190 →

去年

Senate Advances Patent Reform Bill That Could Revitalize Biotech Innovation and Diagnostics

4个月前

Prometheus Laboratories Advances Next-Generation Blood Test for MASH Patient Identification

3个月前

临床试验

Mayo Clinic IBD Biobank

Mayo Clinic Phage Program Biobank

Mayo Clinic Precure - Prospective Study

药物

V-934/V-935

rHIgM12B7(Mayo Clinic)

Phenoxymethylpenicillin(Pen VK)

机构

PROMETHEUS LABORATORIES INC.

Prometheus Biosciences, Inc.

MAYO CLINIC

资讯

Senate Advances Patent Reform Bill That Could Revitalize Biotech Innovation and Diagnostics

Prometheus Laboratories Advances Next-Generation Blood Test for MASH Patient Identification

Jeff Bezos's Prometheus Raises $12B to Build AI That Could Transform Drug Discovery